Clinical Trial Update: Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated consistency across three production lots of GSK Biologicals' HRV rotavirus vaccine; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED